Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02178098 · ClinicalTrials.gov registry record · Phase 2

Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension

A Phase 2 study of Hypertension and Hypercholesterolemia, sponsored by Esperion Therapeutics.

Completed
Registry status
Phase 2
Development phase
143
Enrollment target
20
Study locations

NCT02178098 is a Phase 2 study of Hypertension and Hypercholesterolemia that has completed, run by Esperion Therapeutics. The registered enrollment target is 143 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02178098, a Phase 2 study of Hypertension and Hypercholesterolemia, has completed, sponsored by Esperion Therapeutics.

COMPLETED
Registry status
Phase 2
Development phase
143 participants
Enrollment target
20
Study locations

Study Summary

This Phase 2 study will assess the efficacy and safety of ETC-1002 monotherapy versus placebo in participants with hypercholesterolemia and hypertension.

Conditions Studied

Hypertension Hypercholesterolemia

Interventions

  • DRUG Placebo
  • DRUG ETC-1002

Study Locations (20)

Florida

  • - DeLand
  • - Fort Lauderdale
  • - Hialeah
  • - Oviedo
  • - Pembroke Pines
  • - Pembroke Pines
  • - Port Orange

Alabama

  • - Birmingham
  • - Muscle Shoals

Arizona

  • - Chandler
  • - Glendale

Illinois

  • - Chicago
  • - Gurnee

California

  • - Los Angeles

Idaho

  • - Meridian

Indiana

  • - Indianapolis

Kentucky

  • - Paducah

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2014-06-16
Est. Completion 2015-05-22
Phase Phase 2

Sponsor

Esperion Therapeutics

23 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02178098

The ClinicalTrials.gov registry entry for NCT02178098 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The listed sponsor is Esperion Therapeutics, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02178098 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT02178098 about?

NCT02178098 is a clinical study titled "Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension". This Phase 2 study will assess the efficacy and safety of ETC-1002 monotherapy versus placebo in participants with hypercholesterolemia and hypertension.

What is the current status of trial NCT02178098?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 143 participants. The study started on 2014-06-16. Estimated completion is 2015-05-22.

What conditions does trial NCT02178098 study?

This clinical trial studies the following conditions: Hypertension, Hypercholesterolemia.

What interventions are being tested in trial NCT02178098?

The interventions under investigation include: Placebo (DRUG), ETC-1002 (DRUG).

Who is sponsoring clinical trial NCT02178098?

This trial is sponsored by Esperion Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02178098 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Hypercholesterolemia

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.